Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2018 · 10-Q
Revenue$199.00K$199.00K+45.3% vs Q1 2017 Net Income-$3.58M-$3.58MN/M vs Q1 2017 EPS Diluted-$0.09-$0.09N/M vs Q1 2017 Operating Income-$3,620,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$3,041,000N/M Margins · derivedOperating margin-1819.1%+279.4 pt vs Q1 2017
Net margin-1801.0%+298.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 10, 2018 · 40 d after period end